The differential diagnosis of suspected multiple sclerosis has been developed using data from North America, northern Europe, and Australasia, with a focus on White populations. People from minority ethnic and racial backgrounds in regions where prevalence of multiple sclerosis is high are more often negatively affected by social determinants of health, compared with White people in these regions. A better understanding of changing demographics, the clinical characteristics of people from minority ethnic or racial backgrounds, and the social challenges they face might facilitate equitable clinical approaches when considering a diagnosis of multiple sclerosis. Neuromyelitis optica, systemic lupus erythematous, neurosarcoidosis, infections, and cerebrovascular conditions (eg, hypertension) should be considered in the differential diagnosis of multiple sclerosis for people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia. The diagnosis of multiple sclerosis in people from a minority ethnic or racial background in these regions requires a comprehensive approach that considers the complex interplay of immigration, diagnostic inequity, and social determinants of health.

中文翻译：

---

疑似多发性硬化症的鉴别诊断：北美、北欧和澳大拉西亚少数族裔和种族背景人群的注意事项


疑似多发性硬化症的鉴别诊断是使用来自北美、北欧和澳大拉西亚的数据开发的，重点是白人人群。与这些地区的白人相比，在多发性硬化症患病率高的地区，来自少数民族和种族背景的人更容易受到健康社会决定因素的负面影响。更好地了解不断变化的人口统计数据、少数族裔或种族背景的人的临床特征以及他们面临的社会挑战，可能有助于在考虑多发性硬化症的诊断时采用公平的临床方法。在北美、北欧和澳大拉西亚的少数族裔和种族背景人群的多发性硬化症鉴别诊断中，应考虑视神经脊髓炎、系统性红斑狼疮、神经结节病、感染和脑血管疾病（如高血压）。在这些地区，来自少数民族或种族背景的人群诊断多发性硬化症需要一种全面的方法，该方法考虑了移民、诊断不平等和健康的社会决定因素之间的复杂相互作用。